Prenatal Testing and Newborn Screening Market Mergers and Acquisitions, Industry Drivers, Restraints and Forecasts by 2027 – FortBendNow

The Global prenatal screening and neonatal screening market The report presents comprehensive information covering relevant data for businesses and investors for the period 2020-2027. The report studies the historical data of the Prenatal Testing and Newborn Screening market and offers valuable insights into key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimate of the Prenatal Screening & Newborn Screening industry based on recent technological advancements and research. It also offers valuable data to help investors formulate strategic business investment plans and capitalize on the emerging growth prospects in the Prenatal Screening & Newborn Screening market.

The study on the Global Prenatal Testing and Newborn Screening Market is the latest report covering the impact analysis of the COVID-19 pandemic currently underway. The pandemic has directly affected the market by causing disruptions in global supply chains and indirectly by causing financial hardship. The Prenatal Screening and Newborn Screening market has witnessed dynamic changes in trends and demands owing to the ongoing COVID-19 pandemic. The report provides a detailed overview of how the pandemic has affected key segments of the Prenatal Screening and Newborn Screening industry. The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall Prenatal Testing and Newborn Screening industry

Rising prevalence of chromosomal syndrome in babies is one of the significant factors influencing the growth of the market.

Prenatal Testing and Newborn Screening Market Size – USD 4,124.3 million in 2019, Market Growth – CAGR of 12.8%, Market Trends – Rising demand for non-invasive techniques

To learn more about the report: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market

Major participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

The report further assesses market dynamics, market landscape, company profiles, production and manufacturing capacity, year-over-year growth rate, SWOT analysis, and market analysis. Porter’s five forces. It offers an in-depth assessment of the major companies operating in the market based on their expansion plans, market position, financial position, and gross profit margins.

The prenatal testing and newborn screening market is witnessing high demand attributed to its growing application in detecting fetal chromosomal abnormalities. Prenatal screening is considered superior to other screening modalities, especially for trisomy 21 (one of the most common birth defects). Prenatal testing allows individuals to make informed decisions about whether diagnostic tests should be performed. Associated fetal chromosomal abnormalities usually include the benefit or absence of genetic material which may differ from small segments to small segments of chromosomes to whole chromosomes.

Rising popularity among pregnant women as an alternative to amniocentesis and awareness of genetic issues in fetuses and newborns are driving the prenatal testing and newborn screening market.

In April 2019, Progenity Inc. announced the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases. Ultrasound is expected to observe a significant growth rate during the forecast period, due to the ability of ultrasound diagnostics to detect abnormalities in the baby’s position and actions in the womb.

The hospital held a substantial market share in 2019 due to increasing introduction of non-invasive prenatal tests coupled with rapid technological developments in newborn screening, presence of skilled professionals and better reimbursement scenario. North America dominated the Prenatal Testing and Newborn Screening market in 2019 owing to the availability of state-of-the-art healthcare research system and developments in whole genome sequencing.

Get an example of the report:https://www.emergenresearch.com/request-sample/346

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, type of test, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Prenatal test
  • Newborn screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Mass spectrometry
  • Electrophoresis
  • Enzyme immunoassays
  • DNA analyzes

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Ultrasound
  • Reagent and assay kits
  • Tandem Quadrupole Detector
  • Shaker Incubator
  • Hearing screen instruments

End User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Maternity and specialty clinics
  • Diagnostic centers

Table of Contents Highlights:

1. Report overview
1.1 Scope of research
1.2 Major Prenatal Screening & Newborn Screening Market Segments
1.3 Main players
1.4 Market Analysis by Product
1.5 Market Analysis by Application
1.6 Chronology of the report

2. Global Growth Trends
2.1 Global Prenatal Screening & Newborn Screening Market Size
2.2 Latest Prenatal Screening & Newborn Screening Market Trends
2.3 Key Growth Trends

3. Competitive landscape
3.1 Global Prenatal Screening & Newborn Screening Market Key Players
3.2 Global Prenatal Testing and Newborn Screening Size by Manufacturers
3.3 Major Players Products
3.4 Barriers to Entry into the Prenatal Screening & Newborn Screening Market
3.5 Mergers, acquisitions, joint ventures and strategic alliances

Key questions answered by the report:

What is the Prenatal Testing and Newborn Screening market growth rate? What is the anticipated market valuation of the Prenatal Screening & Newborn Screening industry by 2027?

What are the major growth and restraining factors of the Prenatal Testing and Newborn Screening market?

Who are the major players operating in the market? What are the main strategies adopted by these companies?

What are the major opportunities and growth prospects of the Prenatal Screening & Newborn Screening industry over the forecast period?

Which region is expected to show significant growth in the coming years?

regional segmentation;

North America (US, Canada)

Europe (UK, Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)

Request a discount on the report: https://www.emergenresearch.com/request-discount/346

Related reports:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

RNA Transcriptomics Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in healthcare: https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.

Contact us:

Eric Lee

Corporate Sales Specialist

Emerging Research | The Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

Email: [email protected]

Facebook | LinkdIn | Twitter | Blogs

Comments are closed.